In the wake of a staggering winter where nearly 40%1 of U.S. households were confronted with either COVID-19, influenza, or RSV, the importance of early detection and robust monitoring systems cannot be overstated. Watch our illuminating exploration into the potential of wastewater data in infectious disease surveillance. Discover how wastewater, when integrated with other key data sources and models, can serve as a leading indicator of community-level respiratory disease trends and proactively shape our response strategies.
This exclusive webinar is tailored for Public Health and Pharma Leaders, featuring Alexandria (Ali) Boehm, PhD, principal investigator at WastewaterSCAN, a national program measuring infectious disease targets in wastewater solids across the United States. Ali joined BlueDot’s Head of Epidemiology, Andrea Thomas, PhD, and Data Scientist, Lauren McKenzie. Together, they unveiled the real-time applications of wastewater surveillance, its pivotal role in now-casting the influenza season, and where it will be used next.
In this webinar you’ll learn about:
How wastewater surveillance can be used to track respiratory illness, including Influenza, RSV, and COVID-19 and how it compares with more traditional disease surveillance.
Wastewater Surveillance for Comprehensive Pathogen Insight – Explore the statistically significant correlation between influenza wastewater data and community-level incidence, as well as the dynamic lead-time it provides over indicator-based surveillance data. Learn about wastewater surveillance of Respiratory Syncytial Virus (RSV), COVID-19 and other pathogens.
Practical Applications and Differentiators – Understand the real-time nature of wastewater data and its application in now-casting the influenza season, as well as pharma use cases that can support informed product planning and stocking strategies, and the unique differentiator (a holistic approach combining multiple models and data sources).
View the recording for an insightful journey into the intersection of wastewater data and public health, offering actionable insights and a roadmap for better surveillance. Fill out the form to access the recording directly.
